Literature DB >> 26646538

A Study on Apoptosis and Anti-apoptotic Status in Wilson Disease.

J Kalita1, V Kumar2, U K Misra2.   

Abstract

Wilson disease (WD) is characterized by hepatolenticular degeneration, but there is no report on apoptosis and anti-apoptotic markers in WD patients with neurological manifestation (WDN). The aim of this study was to evaluate active caspase-3 and X-linked inhibitors of apoptosis protein (XIAP) level in WDN and correlate these with disease severity and markers of death (tumor necrosis factor-alpha (TNF-α), interleukin (IL)-8, malondialdehyde (MDA), and Cu) and survival signals (glutathione). Fifty-four patients with WDN and 36 healthy matched controls were included. Their severity, Burke-Fahn-Marsden (BFM) scores, blood counts, hemoglobin, serum chemistry, ceruloplasmin, and free copper and 24-h urinary copper were measured. Cranial MRI findings were noted. Serum active caspase-3, XIAP, TNF-α, IL-8, and plasma glutathione and MDA were measured using enzyme-linked immunosorbent assay (ELISA), flow cytometry, and spectrophotometer respectively. In the patients with WDN, active caspase-3 (0.55 ± 0.11 vs 0.38 ± 0.06 ng/ml), TNF-α (76.05 ± 29.01 vs 36.05 ± 21.01 pg/ml), IL-8 (590.19 ± 89.19 vs 193.43 ± 71.01 pg/ml), and MDA (4.92 ± 0.39 vs 3.43 ± 0.21 nmol/ml) levels were increased whereas XIAP (84.66 ± 10.39 vs 95.76 ± 10.11 ng/ml) and glutathione (GSH) (2.03 ± 0.29 vs 2.98 ± 0.27 mg/dl) levels were decreased compared to controls. Active caspase-3 was correlated with neurological severity (r = 0.48), BFM score (r = 0.37), ceruloplasmin (r = -0.39), hemoglobin (r = -0.34), and serum Cu (r = 0.39). XIAP levels were correlated with neurological severity (r = -0.40), BFM (r = -0.51), serum Cu (r = -0.42), and ceruloplasmin (r = 0.34). The XIAP level positively correlated with survival (GSH) and inversely with death signals (TNF-α, IL-8, MDA and free serum Cu) whereas active caspase-3 positively correlated with death (TNF-α, IL-8, serum Cu, MDA) and inversely with survival signal (GSH). Serum active caspase-3 level increased in WDN and positively correlated with the severity of disease, death signals (TNF, IL-8, MDA, and free Cu) and inversely with GSH and XIAP.

Entities:  

Keywords:  Apoptosis; Caspase; Copper; Cytokine; Glutathione; Malondialdehyde; Wilson disease; XIAP

Mesh:

Substances:

Year:  2015        PMID: 26646538     DOI: 10.1007/s12035-015-9570-y

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  31 in total

1.  Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress.

Authors:  Hironori Nagasaka; Ikuo Inoue; Ayano Inui; Haruki Komatsu; Tsuyoshi Sogo; Kei Murayama; Tomoko Murakami; Tohru Yorifuji; Kotaro Asayama; Shigeo Katayama; Shinji Uemoto; Kunihiko Kobayashi; Masaki Takayanagi; Tomoo Fujisawa; Hirokazu Tsukahara
Journal:  Pediatr Res       Date:  2006-08-28       Impact factor: 3.756

2.  Worsening of Wilson disease following penicillamine therapy.

Authors:  Jayantee Kalita; Vijay Kumar; Satish Chandra; Bishwanath Kumar; Usha Kant Misra
Journal:  Eur Neurol       Date:  2013-12-17       Impact factor: 1.710

3.  Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP.

Authors:  J Silke; P G Ekert; C L Day; C J Hawkins; M Baca; J Chew; M Pakusch; A M Verhagen; D L Vaux
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

4.  Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride.

Authors:  K H Schosinsky; H P Lehmann; M F Beeler
Journal:  Clin Chem       Date:  1974-12       Impact factor: 8.327

5.  Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms.

Authors:  Radan Bruha; Libor Vitek; Zdenek Marecek; Lenka Pospisilova; Sona Nevsimalova; Pavel Martasek; Jaromir Petrtyl; Petr Urbanek; Alena Jiraskova; Ivana Malikova; Martin Haluzik; Peter Ferenci
Journal:  J Inherit Metab Dis       Date:  2011-12-03       Impact factor: 4.982

6.  Regulation of the copper chaperone CCS by XIAP-mediated ubiquitination.

Authors:  Graham F Brady; Stefanie Galbán; Xuwen Liu; Venkatesha Basrur; Jonathan D Gitlin; Kojo S J Elenitoba-Johnson; Thomas E Wilson; Colin S Duckett
Journal:  Mol Cell Biol       Date:  2010-02-12       Impact factor: 4.272

7.  A single BIR domain of XIAP sufficient for inhibiting caspases.

Authors:  R Takahashi; Q Deveraux; I Tamm; K Welsh; N Assa-Munt; G S Salvesen; J C Reed
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

8.  A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings.

Authors:  Jayantee Kalita; Vijay Kumar; Usha K Misra; Abhay Ranjan; Hamidullah Khan; Rituraj Konwar
Journal:  J Neuroimmunol       Date:  2014-06-24       Impact factor: 3.478

9.  Comparison of functional and structural brain disturbances in Wilson's disease.

Authors:  G Grimm; L Prayer; W Oder; P Ferenci; C Madl; P Knoflach; B Schneider; H Imhof; A Gangl
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

Review 10.  Diagnosis and treatment of Wilson's disease.

Authors:  G J Brewer; J K Fink; P Hedera
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

View more
  10 in total

1.  Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury.

Authors:  Jayantee Kalita; Vijay Kumar; Usha K Misra; Sunil Kumar
Journal:  J Mol Neurosci       Date:  2020-07-13       Impact factor: 3.444

2.  Memory and Learning Dysfunction Following Copper Toxicity: Biochemical and Immunohistochemical Basis.

Authors:  Jayantee Kalita; Vijay Kumar; Usha K Misra; Himangsu K Bora
Journal:  Mol Neurobiol       Date:  2017-05-23       Impact factor: 5.590

3.  Pontomesencephalic Atrophy and Postural Instability in Wilson Disease.

Authors:  J Kalita; S Naik; S K Bhoi; U K Misra; A Ranjan; S Kumar
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-11       Impact factor: 3.825

4.  Movement Disorder in Copper Toxicity Rat Model: Role of Inflammation and Apoptosis in the Corpus Striatum.

Authors:  Jayantee Kalita; Vijay Kumar; Usha K Misra; Himangsu K Bora
Journal:  Neurotox Res       Date:  2019-12-06       Impact factor: 3.911

5.  Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity.

Authors:  Jayantee Kalita; Vijay Kumar; Vasudev Parashar; Usha K Misra
Journal:  Mol Neurobiol       Date:  2021-08-26       Impact factor: 5.590

6.  Case of Early-Onset Parkinson's Disease in a Heterozygous Mutation Carrier of the ATP7B Gene.

Authors:  Ekaterina Y Ilyechova; Irina V Miliukhina; Marina N Karpenko; Iurii A Orlov; Ludmila V Puchkova; Sergey A Samsonov
Journal:  J Pers Med       Date:  2019-08-17

7.  HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson's Disease.

Authors:  Peter Ferenci; Jan Pfeiffenberger; Albert Friedrich Stättermayer; Rudolf E Stauber; Claudia Willheim; Karl H Weiss; Petra Munda-Steindl; Michael Trauner; Michael Schilsky; Heinz Zoller
Journal:  JHEP Rep       Date:  2019-03-19

8.  Dysregulated Choline, Methionine, and Aromatic Amino Acid Metabolism in Patients with Wilson Disease: Exploratory Metabolomic Profiling and Implications for Hepatic and Neurologic Phenotypes.

Authors:  Tagreed A Mazi; Gaurav V Sarode; Anna Czlonkowska; Tomasz Litwin; Kyoungmi Kim; Noreene M Shibata; Valentina Medici
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

9.  System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of GanDouLing for Wilson's Disease.

Authors:  Juan Zhang; Hong Chen; Yuancheng Bao; Daojun Xie; Wenming Yang; Huaizhou Jiang; Ting Dong; Hui Han
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-29       Impact factor: 2.629

Review 10.  Proteotoxicity: A Fatal Consequence of Environmental Pollutants-Induced Impairments in Protein Clearance Machinery.

Authors:  Shweta Devi; Jong-Joo Kim; Anand Prakash Singh; Surendra Kumar; Ashish Kant Dubey; Sandeep Kumar Singh; Ravi Shankar Singh; Vijay Kumar
Journal:  J Pers Med       Date:  2021-01-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.